Mo1160: EXTERNAL VALIDATION OF A PREDICTIVE MODEL DETERMINING RISK OF NEOPLASTIC PROGRESSION OF BARRETT'S ESOPHAGUS IN A COHORT OF UNITED STATES VETERANS
Nguyen T, Thrift A, Ketwaroo G, Du X, Novelo L, George R, Rosen D, El-Serag H. Mo1160: EXTERNAL VALIDATION OF A PREDICTIVE MODEL DETERMINING RISK OF NEOPLASTIC PROGRESSION OF BARRETT'S ESOPHAGUS IN A COHORT OF UNITED STATES VETERANS. Gastroenterology 2022, 162: s-719. DOI: 10.1016/s0016-5085(22)61693-7.Peer-Reviewed Original ResearchExternal validation of a model determining risk of neoplastic progression of Barrett’s esophagus in a cohort of U.S. veterans
Nguyen T, Thrift A, Ketwaroo G, Du X, Leon Novelo L, George R, Rosen D, El-Serag H. External validation of a model determining risk of neoplastic progression of Barrett’s esophagus in a cohort of U.S. veterans. Gastrointestinal Endoscopy 2022, 95: 1113-1122. PMID: 34998796, PMCID: PMC9119926, DOI: 10.1016/j.gie.2021.12.034.Peer-Reviewed Original ResearchConceptsHigh-grade dysplasiaHigh-risk groupEsophageal adenocarcinomaBarrett's esophagusBE patientsDiscriminatory abilityHouston Veterans Affairs Medical CenterVeterans Affairs Medical CenterHGD/esophageal adenocarcinomaRetrospective cohort studyExternal validationExternal validation studyInitial EGDCohort studyConsecutive patientsSmoking statusDysplasia statusRisk groupsMedical CenterHigh riskGeneral populationNew diagnosisPatientsClinical practiceBiopsy sampling